ClearPoint Neuro, Inc. (CLPT)

5.31 -0.01 (-0.19%) At close: 04:00PM EDT

ClearPoint Neuro, Inc.

120 S. Sierra Avenue
Suite 100
Solana Beach, CA 92075
United States
888 287 9109
https://www.clearpointneuro.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 107

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Danilo D'Alessandro	Chief Financial Officer	459.26k	N/A	1986
Mr. Jeremy Stigall	Chief Business Officer	392.66k	N/A	1984
Mr. Mazin Sabra	Chief Operating Officer	N/A	N/A	1981
Ms. Ellisa Cholapranee	General Counsel & Secretary	N/A	N/A	N/A
Ms. Jacqueline Keller	Vice President of Marketing	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Corporate governance

ClearPoint Neuro, Inc.’s ISS governance QualityScore as of 1 April 2024 is 5. The pillar scores are Audit: 7; Board: 3; Shareholder rights: 6; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.